These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 24347127
1. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques. Aljaroudi WA, Desai MY, Tang WH, Phelan D, Cerqueira MD, Jaber WA. J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127 [Abstract] [Full Text] [Related]
2. Molecular imaging of amyloidosis: will the heart be the next target after the brain? Chen W, Dilsizian V. Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845 [Abstract] [Full Text] [Related]
3. Advances in PET-Based Cardiac Amyloid Radiotracers. Gallegos C, Miller EJ. Curr Cardiol Rep; 2020 May 19; 22(6):40. PubMed ID: 32430600 [Abstract] [Full Text] [Related]
4. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Hutt DF, Quigley AM, Page J, Hall ML, Burniston M, Gopaul D, Lane T, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD. Eur Heart J Cardiovasc Imaging; 2014 Nov 19; 15(11):1289-98. PubMed ID: 24939945 [Abstract] [Full Text] [Related]
5. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy. Papantoniou V, Valsamaki P, Kastritis S, Tsiouris S, Delichas Z, Papantoniou Y, Tsiouma M, Athanasoulis T, Fotopoulos A, Dimopoulos MA. Hell J Nucl Med; 2015 Nov 19; 18 Suppl 1():42-50. PubMed ID: 26665211 [Abstract] [Full Text] [Related]
6. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction. Chen W, Ton VK, Dilsizian V. Curr Cardiol Rep; 2018 Mar 08; 20(4):23. PubMed ID: 29520480 [Abstract] [Full Text] [Related]
11. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis. Brownrigg J, Lorenzini M, Lumley M, Elliott P. ESC Heart Fail; 2019 Oct 08; 6(5):1041-1051. PubMed ID: 31487121 [Abstract] [Full Text] [Related]
13. Cardiac amyloidosis: updates in diagnosis and management. Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A. Arch Cardiovasc Dis; 2013 Oct 08; 106(10):528-40. PubMed ID: 24070600 [Abstract] [Full Text] [Related]
14. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, Guendouz S, Tissot CM, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Itti E, Meignan M, Damy T. Amyloid; 2015 Oct 08; 22(4):210-20. PubMed ID: 26465835 [Abstract] [Full Text] [Related]
16. 99mTechnetium pyrophosphate scintigraphy with cadmium zinc telluride cameras is a highly sensitive and specific imaging modality to diagnose transthyretin cardiac amyloidosis. Flaherty KR, Morgenstern R, Pozniakoff T, DeLuca A, Castano A, Maurer MS, Bokhari S. J Nucl Cardiol; 2020 Apr 08; 27(2):371-380. PubMed ID: 31463816 [Abstract] [Full Text] [Related]
17. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with 99m Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow. Saleem M, Sadat B, Van Harn M, Ananthasubramaniam K. Medicina (Kaunas); 2023 Feb 16; 59(2):. PubMed ID: 36837580 [Abstract] [Full Text] [Related]
20. Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature. Frantellizzi V, Cosma L, Pani A, Pontico M, Conte M, De Angelis C, De Vincentis G. Curr Med Imaging; 2020 Feb 16; 16(8):957-966. PubMed ID: 33081658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]